San Francisco Sentry Investment Group’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-2,325
| Closed | -$36K | – | 879 |
|
|
2018
Q2 | $36K | Sell |
2,325
-3,652
| -61% | -$56.5K | 0.01% | 417 |
|
|
2018
Q1 | $134K | Buy |
5,977
+250
| +4% | +$5.61K | 0.04% | 323 |
|
|
2017
Q4 | $172K | Buy |
5,727
+1,300
| +29% | +$39K | 0.05% | 281 |
|
|
2017
Q3 | $167K | Sell |
4,427
-52
| -1% | -$1.96K | 0.06% | 270 |
|
|
2017
Q2 | $125K | Buy |
+4,479
| New | +$125K | 0.04% | 279 |
|
|
2014
Q4 | – | Sell |
-2,790
| Closed | -$69K | – | 159 |
|
|
2014
Q3 | $69K | Buy |
2,790
+1,040
| +59% | +$25.7K | 0.03% | 264 |
|
|
2014
Q2 | $40K | Buy |
1,750
+1,450
| +483% | +$33.1K | 0.02% | 345 |
|
|
2014
Q1 | $7K | Hold |
300
| – | – | ﹤0.01% | 562 |
|
|
2013
Q4 | $7K | Buy |
+300
| New | +$7K | ﹤0.01% | 534 |
|